CRYOPORT, INC. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
CRYOPORT, INC. (CYRX) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $2.52 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2025-03-07
- CRYOPORT, INC. effective income tax rate reconciliation, other reconciling items, amount for the quarter ending 2015-03-31 was $873.60K, a 18891.30% increase year-over-year.
- CRYOPORT, INC. effective income tax rate reconciliation, other reconciling items, amount for the quarter ending 2014-03-31 was $4.60K.
- CRYOPORT, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was $2.52M.
- CRYOPORT, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was -$172.00K, a 148.86% decline from fiscal 2022.
- CRYOPORT, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was $352.00K, a 56.70% decline from fiscal 2021.
- CRYOPORT, INC. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2021 was $813.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 3 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 9 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | $2.52M 10-K · filed 2025-03-07 | |||
| 2023-12-31 | -$172.00K 10-K · filed 2025-03-07 | |||
| 2022-12-31 | $352.00K 10-K · filed 2025-03-07 | |||
| 2021-12-31 | $813.00K 10-K · filed 2024-03-13 | |||
| 2020-12-31 | -$375.00K 10-K · filed 2023-02-28 | |||
| 2019-12-31 | -$126.00K 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $58.00K 10-K · filed 2020-03-10 | $82.00K 10-K · filed 2019-03-13 | ||
| 2017-12-31 | $56.00K 10-K · filed 2019-03-13 | |||
| 2016-12-31 | $41.00K 10-KT · filed 2017-03-13 | $41.00K 10-K · filed 2018-03-08 | ||
| 2016-03-31 | $184.00K 10-KT · filed 2017-03-13 | |||
| 2015-03-31 | $873.60K 10-K · filed 2015-05-19 | $874.00K 10-K · filed 2016-06-28 | ||
| 2014-03-31 | $4.60K 10-K · filed 2015-05-19 | $4.60K 10-K · filed 2014-06-25 | ||
| 2013-03-31 | $215.60K 10-K · filed 2014-06-25 | |||
| 2012-03-31 | $35.60K 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |